neutral
5 days agoThyrocare Shares Drop Sharply as Stock Turns Ex-Bonus in 2:1 Issue
Thyrocare Technologies witnessed a sharp price adjustment today, opening at Rs 510 on the NSE compared with the previous close of Rs 1,475.10. The decline of over 65 percent reflected the stock turning ex-bonus under a 2:1 issuance, giving investors two additional shares for every one held. The company’s capital structure remains unchanged, with the face value intact and no equity dilution involved. Market experts noted that the movement was technical and not linked to fundamentals.
Explore:Mutual Fund Tools
neutral
5 days agoThyrocare Shares Drop Sharply as Stock Turns Ex-Bonus in 2:1 Issue
Thyrocare Technologies witnessed a sharp price adjustment today, opening at Rs 510 on the NSE compared with the previous close of Rs 1,475.10. The decline of over 65 percent reflected the stock turning ex-bonus under a 2:1 issuance, giving investors two additional shares for every one held. The company’s capital structure remains unchanged, with the face value intact and no equity dilution involved. Market experts noted that the movement was technical and not linked to fundamentals.
Explore:Mutual Fund Tools
1 min read
76 words
Thyrocare’s steep price drop reflected its 2:1 bonus adjustment, with analysts stressing no equity dilution and no change in the company’s fundamentals.
Thyrocare Technologies witnessed a sharp price adjustment today, opening at Rs 510 on the NSE compared with the previous close of Rs 1,475.10. The decline of over 65 percent reflected the stock turning ex-bonus under a 2:1 issuance, giving investors two additional shares for every one held. The company’s capital structure remains unchanged, with the face value intact and no equity dilution involved. Market experts noted that the movement was technical and not linked to fundamentals.
Thyrocare Technologies witnessed a sharp price adjustment today, opening at Rs 510 on the NSE compared with the previous close of Rs 1,475.10. The decline of over 65 percent reflected the stock turning ex-bonus under a 2:1 issuance, giving investors two additional shares for every one held. The company’s capital structure remains unchanged, with the face value intact and no equity dilution involved. Market experts noted that the movement was technical and not linked to fundamentals.
Nov 28, 2025 • 04:45